TY - JOUR
T1 - Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report
T2 - Generation and Reduction of Candidate Criteria
AU - the New APS Classification Criteria Collaborators
AU - Barbhaiya, Medha
AU - Zuily, Stephane
AU - Ahmadzadeh, Yasaman
AU - Amigo, Mary Carmen
AU - Avcin, Tadej
AU - Bertolaccini, Maria Laura
AU - Branch, D. Ware
AU - de Jesus, Guilherme
AU - Devreese, Katrien M.J.
AU - Frances, Camille
AU - Garcia, David
AU - Guillemin, Francis
AU - Levine, Steven R.
AU - Levy, Roger A.
AU - Lockshin, Michael D.
AU - Ortel, Thomas L
AU - Seshan, Surya V.
AU - Tektonidou, Maria
AU - Wahl, Denis
AU - Willis, Rohan
AU - Naden, Ray
AU - Costenbader, Karen
AU - Erkan, Doruk
AU - Agmon-Levin, Nancy
AU - Aguilar, Cassyanne
AU - Alba, Paula
AU - Alpan, Oral
AU - Ambrozic, Ales
AU - Amoura, Zahir
AU - Andrade, Danieli
AU - Andrade, Luis
AU - Appenzeller, Simone
AU - Esen, Bahar Artim
AU - Atsumi, Tatsuya
AU - Berkun, Yackov
AU - Cabral, Antonio
AU - Canaud, Guillaume
AU - Cervera, Ricard
AU - Chen, Pojen
AU - Chighizola, Cecilia
AU - Cimaz, Rolando
AU - Cohen, Hannah
AU - Costedoat-Chalumeau, Nathalie
AU - Crowther, Mark
AU - Cuadrado, Maria Jose
AU - de Groot, Philip G.
AU - de Moerloose, Philippe
AU - Derksen, Ronald
AU - Diz-Kucukkaya, Reyhan
AU - Gonzalez, Emilio B.
N1 - Publisher Copyright:
© 2020, American College of Rheumatology
PY - 2021/10
Y1 - 2021/10
N2 - Objective: An international multidisciplinary initiative, jointly supported by the American College of Rheumatology and European Alliance of Associations for Rheumatology, is underway to develop new rigorous classification criteria to identify patients with high likelihood of antiphospholipid syndrome (APS) for research purposes. The present study was undertaken to apply an evidence- and consensus-based approach to identify candidate criteria and develop a hierarchical organization of criteria within domains. Methods: During phase I, the APS classification criteria steering committee used systematic literature reviews and surveys of international APS physician scientists to generate a comprehensive list of items related to APS. In phase II, we reviewed the literature, administered surveys, formed domain subcommittees, and used Delphi exercises and nominal group technique to reduce potential APS candidate criteria. Candidate criteria were hierarchically organized into clinical and laboratory domains. Results: Phase I generated 152 candidate criteria, expanded to 261 items with the addition of subgroups and candidate criteria with potential negative weights. Using iterative item reduction techniques in phase II, we initially reduced these items to 64 potential candidate criteria organized into 10 clinical and laboratory domains. Subsequent item reduction methods resulted in 27 candidate criteria, hierarchically organized into 6 additive domains (laboratory, macrovascular, microvascular, obstetric, cardiac, and hematologic) for APS classification. Conclusion: Using data- and consensus-driven methodology, we identified 27 APS candidate criteria in 6 clinical or laboratory domains. In the next phase, the proposed candidate criteria will be used for real-world case collection and further refined, organized, and weighted to determine an aggregate score and threshold for APS classification.
AB - Objective: An international multidisciplinary initiative, jointly supported by the American College of Rheumatology and European Alliance of Associations for Rheumatology, is underway to develop new rigorous classification criteria to identify patients with high likelihood of antiphospholipid syndrome (APS) for research purposes. The present study was undertaken to apply an evidence- and consensus-based approach to identify candidate criteria and develop a hierarchical organization of criteria within domains. Methods: During phase I, the APS classification criteria steering committee used systematic literature reviews and surveys of international APS physician scientists to generate a comprehensive list of items related to APS. In phase II, we reviewed the literature, administered surveys, formed domain subcommittees, and used Delphi exercises and nominal group technique to reduce potential APS candidate criteria. Candidate criteria were hierarchically organized into clinical and laboratory domains. Results: Phase I generated 152 candidate criteria, expanded to 261 items with the addition of subgroups and candidate criteria with potential negative weights. Using iterative item reduction techniques in phase II, we initially reduced these items to 64 potential candidate criteria organized into 10 clinical and laboratory domains. Subsequent item reduction methods resulted in 27 candidate criteria, hierarchically organized into 6 additive domains (laboratory, macrovascular, microvascular, obstetric, cardiac, and hematologic) for APS classification. Conclusion: Using data- and consensus-driven methodology, we identified 27 APS candidate criteria in 6 clinical or laboratory domains. In the next phase, the proposed candidate criteria will be used for real-world case collection and further refined, organized, and weighted to determine an aggregate score and threshold for APS classification.
UR - http://www.scopus.com/inward/record.url?scp=85102902324&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85102902324&partnerID=8YFLogxK
U2 - 10.1002/acr.24520
DO - 10.1002/acr.24520
M3 - Article
C2 - 33253499
AN - SCOPUS:85102902324
SN - 2151-464X
VL - 73
SP - 1490
EP - 1501
JO - Arthritis Care and Research
JF - Arthritis Care and Research
IS - 10
ER -